跳至主要内容
临床试验/NCT02563665
NCT02563665撤回不适用

A Prospective Study on Safety and Efficacy of Sofosbuvir Based Antiviral Regimen for Treating Hepatitis C in Patients With Moderate to Advanced Chronic Kidney Disease and Patients Receiving Renal Replacement Therapy

Institute of Liver and Biliary Sciences, India1 个研究点 分布在 1 个国家开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Sustained Virologic Response 24 defined as HCV RNA <Lower Level of Qunatification 24 weeks after discontinuation of therapy.

研究概览

简要总结

All patients with chronic kidney disease (stages 3, 4 and 5) and chronic dialysis patients with HCV infection attending nephrology and Hepatology OPD or getting outpatient dialysis at the dialysis unit of ILBS.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with moderate to severe renal dysfunction (CKD stage 3, 4, 5) and chronic dialysis patients
  • Patients consented for the study protocol by signing the informed consent.

排除标准

  • Age less than 18 years
  • Confirmed pregnancy
  • HCV-HIV Co infection
  • HBV-HCV co infection

结局指标

主要结局

Sustained Virologic Response 24 defined as HCV RNA <Lower Level of Qunatification 24 weeks after discontinuation of therapy.

时间窗: 1 year

次要结局

  • number of adverse Events in both groups(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Safety and Efficacy of Sofosbuvir Based Antiviral... | 临床试验